CACaption Management, LLC
Institutional investor · Portfolio as of Q2 2019
Top Holdings641 positions
ANADARKO PETE CORP | 686,900 | $48.5M | 2.4% | — | — | — | New — |
Amgen Inc | 261,300 | $48.2M | 2.4% | — | — | — | New — |
UNIQURE NV | 600,800 | $47M | 2.4% | — | — | — | Increased — |
DaVita Inc | 535,800 | $30.1M | 1.5% | — | — | — | New — |
MEDICINES CO | 781,300 | $28.5M | 1.4% | — | — | — | Increased — |
Centene Corp | 514,000 | $27M | 1.4% | — | — | — | Increased — |
Mirati Therapeutics Inc | 257,200 | $26.5M | 1.3% | — | — | — | Increased — |
MEDICINES CO | 654,200 | $23.9M | 1.2% | — | — | — | Increased — |
WellCare Health Plans Inc | 77,200 | $22M | 1.1% | — | — | — | New — |
Targa Resources Corp | 552,100 | $21.7M | 1.1% | — | — | — | Unchanged — |
Beyond Meat Inc | 130,000 | $20.9M | 1.1% | — | — | — | New — |
SPDR S&P 500 ETF Trust | 70,000 | $20.5M | 1.0% | — | — | — | New — |
BIOHAVEN PHARMACTL HLDG CO L | 391,800 | $17.2M | 0.9% | — | — | — | New — |
Union Pacific Corp | 100,000 | $16.9M | 0.9% | — | — | — | Unchanged — |
Marathon Petroleum Corp | 300,000 | $16.8M | 0.8% | — | — | — | New — |
| 250,400 | $16.4M | 0.8% | — | — | — | New — | |
Tractor Supply Co | 150,000 | $16.3M | 0.8% | — | — | — | New — |
Edison International | 242,000 | $16.3M | 0.8% | — | — | — | Increased — |
Ferrari NV | 100,700 | $16.3M | 0.8% | — | — | — | New — |
Exact Sciences Corp | 133,800 | $15.8M | 0.8% | — | — | — | Decreased — |
Caption Management, LLC manages $2B across 641 positions as of Q2 2019. Top holdings: APC puts (2.4%), AMGN puts (2.4%), QURE calls (2.4%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1/5.0.
Active quarter - 155 new positions, 110 exits, 32 increased. No standout high-conviction moves this quarter. Portfolio: $2.0B across 641 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR